Prader-Willi Syndrome (PWS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

 Prader-Willi syndrome (PWS) is a genetic disorder due to the loss of function of specific genes. In newborns, symptoms include weak muscles, poor feeding, and slow development. Beginning in childhood, the person becomes constantly hungry, which often leads to obesity and T2D.

·       Patients with Prader-Willi syndrome (PWS) frequently reach adulthood and are able to function in a group home setting, perform vocational work, or attend community college classes. Diminished sensitivity to pain and diminished capacity to vomit may delay the diagnosis of underlying disease

·       According to Thelansis’s research, prevalence at birth is estimated at 1/15,000-30,000 worldwide. Most estimates place the incidence between 1 in 10,000-30,000 individuals in the general population and about 350,000-400,000 individuals worldwide. PWS affects males and females in equal numbers and occurs in all ethnic groups and geographic regions in the world

·       Although specific treatments vary depending on symptoms, most children with PWS will need the following: good nutrition for infants, Human growth hormone (HGH) treatment, sex hormone treatment, weight management, treatment of sleep disturbances, etc.

Thelansis’s “Prader-Willi Syndrome (PWS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Prader-Willi Syndrome (PWS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Prader-Willi Syndrome (PWS) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Prader-Willi Syndrome (PWS) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Prader-Willi Syndrome (PWS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032